Patents

US 12336986 B2: Treatment and prevention of ocular neurodegenerative disorder

Granted
2025-06-24
Filed
2022-07-12 application 17862668
Type
Utility · 19 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention relates to the use of a pharmaceutical composition containing nicotinamide (NAM) and/or pyruvate as a neuroprotective medicament or gene therapy in the treatment of neurodegenerative disorders, in particular axon degeneration of neuronal tissue in ocular-related neurodegeneration diseases including glaucoma.

Source: PVGPATDIS, file of 2026-04-10 (ipg250624.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Jackson Laboratory 76 patentsUS company or organizationBar Harbor, MEJACKSON LABORATORY Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Simon JohnBar Harbor, ME11PVGPATDIS, file of 2026-04-10
Peter Alexander WilliamsBar Harbor, ME15PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/455PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P27/06PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y207/07001PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N2750/14143PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-08-11Assignment
Assignment of assignor's interest
WILLIAMS, PETER ALEXANDER signed 2018-08-31
JOHN, SIMON W.M. signed 2018-10-19
THE JACKSON LABORATORY BAR HARBOR60778/594ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.